MedTrace Logo

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women

NCT04201821 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-06-12

Study results available
· View outcomes & findings →

Summary

Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.

Conditions

  • Fecal Incontinence

Interventions

BIOLOGICAL

fecal microbial transplantation (FMT)

Fecal microbial transplantation (FMT) is the infusion of intestinal microbiota from healthy donors.

Sponsors & Collaborators

Principal Investigators

  • Uduak U Andy, MD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-14
Primary Completion
2023-01-18
Completion
2023-01-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04201821 on ClinicalTrials.gov